Modern Care Journal

Published by: Kowsar

The Epidemiology of HBsAg Positive Cases Babol, Iran

Mehdi Safarpour 1 , Seyed Reza Hosseini 2 , Amir Tiyuri 3 , Seyed Mostafa Mirzad 4 and Masume Mohamadzade 5 , *
Authors Information
1 MSc of Epidemiology, Health Deputy, Babol University of Medical Sciences, Babol, IR Iran
2 Professor of Community Medicine, Department of Community Medicine, School of Medicine, Babol University of Medical Sciences, Babol, IR Iran
3 PHD Student of Epidemiology, Department of Epidemiology, School of Health, Iran University of Medical Sciences, Tehran, IR Iran
4 MSc Student of Epidemiology training. Health Deputy, Babol University of Medical Sciences, Babol, IR Iran
5 MSc of Health Services Management, Health Deputy, Babol University of Medical Sciences, Babol, IR Iran
Article information
  • Modern Care Journal: April 2017, 14 (2); e64625
  • Published Online: April 30, 2017
  • Article Type: Research Article
  • Received: February 13, 2017
  • Accepted: April 4, 2017
  • DOI: 10.5812/modernc.64625

To Cite: Safarpour M, Hosseini S R, Tiyuri A, Mostafa Mirzad S, Mohamadzade M. The Epidemiology of HBsAg Positive Cases Babol, Iran, Mod Care J. 2017 ; 14(2):e64625. doi: 10.5812/modernc.64625.

Abstract
Copyright © 2017, Modern Care Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
References
  • 1. Center for Disease Control and Prevention. Viral hepatitis. CDC. 2012, [cited updated April 1, 2008; cited 9/11/2016]. Available from: http://www.cdc.gov/hepatitis/publicinfo.htm#whatishep.
  • 2. Zuckerman JN, Zuckerman AJ. The epidemiology of hepatitis B.The epidemiology of hepatitis B. Clin Liver Dis. 1999;3(2):179-87.
  • 3. Ott MJ, Aruda M. NAPNAP's 21st Annual ConferenceHepatitis B vaccine. J Pediatr Health Care. 1999;13(5):211-6.
  • 4. André F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine. 2000;18(Supplement 1):S20-S2.
  • 5. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006;28:112-25. doi: 10.1093/epirev/mxj009. [PubMed: 16754644].
  • 6. Lin KW, Kirchner JT. Hepatitis B. Am Fam Physician. 2004;69(1):75-82. [PubMed: 14727820].
  • 7. Maddrey WC. Hepatitis B--an important public health issue. Clin Lab. 2001;47(1-2):51-5. [PubMed: 11214223].
  • 8. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54(RR-16):1-31. [PubMed: 16371945].
  • 9. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. Gastroenterol. 2004;38(10):158-68.
  • 10. Salehi-Vaziri M, Sadeghi F, Almasi Hashiani A, Gholami Fesharaki M, Alavian SM. Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis. Hepat Mon. 2016;16(4). e35577. doi: 10.5812/hepatmon.35577. [PubMed: 27257428].
  • 11. Capocaccia R, Sant M, Berrino F, Simonetti A, Santi V, Trevisan IF. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am J Gastroenterol. 2007;102(8):1661-70.
  • 12. Yu MC, Yuan JM. Environmental factors and risk for hepatocellular carcinoma. J Gastro. 2004;127(5 Suppl 1):S72-8.
  • 13. El-Serag HB. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma. J Gastro. 2012;142(6):1264-73.
  • 14. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94(2):153-6. [PubMed: 11668491].
  • 15. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97-107.
  • 16. World Health Organization . WHO expanded programme on immunisation. Report of 14th Global Advisory Group (Antalya, Turkey, Oct 14–18, 1991). Geneva: WHO; 1991.
  • 17. Rezaee R, Aghcheli B, Poortahmasebi V, Qorbani M, Alavian SM, Jazayeri SM. Prevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis Study. Hepat Mon. 2015;15(5). e23618.
  • 18. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212-9. doi: 10.1016/j.vaccine.2011.12.116. [PubMed: 22273662].
  • 19. Ghaffari-fam S, Khami B, Nikbakht HA, Barzkar H, Daemi A, Ahmadi S. EpidemiologicalPatterns and Risk Factors of Hepatitis B & C in North-West Iran, Miyandoab City (West Azerbaijan Province). JCRS. 2016;4(3):119.
  • 20. Karimi G, Kabir K, Delpishe A, Saie mehr K, Nazari A, Barati H. 36-Risk factors for HBsAg positive immigration largest province of Iran.A case - control study matched. Alborz Univer Med J. 2014;4(1):17-26.
  • 21. Mirzaei MAM, Lotfi MH, Alavinia SM, Fallahzadeh MH, Ayatollahi J. Hepatitis B infection in North Khorasan province during March 2010 - February 2012. J North Khorasan Univ Med Sci. 2014;6(2):425-31.
  • 22. Moosazadeh MAM, Nezammahalleh A. The Epidemiology of HBsAg Positive Cases Reported to the Health Deputy of Mazandaran University of Medical Sciences, Iran. J Health Develop. 2012;1(2).
  • 23. Majdzade S, Porajal J. The prevalence of chronic hepatitis B in Iran: review. Iran J Epidemiol. 2009;4(3-4):1-8.
  • 24. Khosravi S, Salehi M, Hatami H, Sanei ME, Alavian S. Sero-epidemiological study of family-members of HBsAg positive chronic carriers in Zahedan city Southeastern Iran. J Health Field. 2013;1(2):1-8.
  • 25. Zali MR, Mohammad K, Noorbala AA, Noorimayer B, Shahraz S. Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran. East Mediterr Health J. 2005;11(1-2):62-7. [PubMed: 16532672].
  • 26. Goldstein ST, Alter MJ, Williams IT, Moyer LA, Judson FN, Mottram K, et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis. 2002;185(6):713-9. doi: 10.1086/339192. [PubMed: 11920288].
  • 27. Alavi-Naini R, Sanei-Moghadam E, Khosravi S, Salahshour H. Changes in risk factors of HBsAg positive blood donors in Zahedan, Iran. Zahedan J Res Med Sc. 2011;13(3):41-6.
  • 28. Papi OA SM, Mokhayeri H, Sheikhazadi A, Chegeni Sharafi A, Nabavi M. Epidemiological study of hepatitis B in Koohdasht and Sepiddasht.1391. Yafteh. 2014;15(4):38-43.
  • 29. Abdolahi N, Keshtkar A, Semnani S, Roshandel G, Beshrat S, Joshaghani H. HBV Seroprevalence among Golestan Adults. Iran J Epidemiol. 2006;2(3):35-40.
  • 30. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007;16(4):403-6. [PubMed: 18193122].
  • 31. Motazakker M, Shokat Nagadeh M, Khalili F, Shayeri B. Hepatitis B Virus Infection among Pregnant Women Attending Health Care Centers of Urmia. J Guilan Univ Med Sci. 2014;23(89):45-50.
  • 32. Mohammadian F, Mazloomzadeh S, Esmaeilzadeh A, Sorouri Zanjani R, Savabi S, Soleimanipor S. Seroprevalenceof Hepatitis B Virus among Pregnant Women Referred to Healthcare Centers of Zanjan. ZUMS J. 2014;22(93):96-104.
  • 33. Cheraghali F, Yazarloo S, Behnampour N, Azarhoush R. Frequency of HBsAg in pregnant women in Gorgan, Iran. J Gorgan Univ Med Sci. 2011;12(4):84-90.
  • 34. Kahn J. Preventing hepatitis A and hepatitis B virus infections among men who have sex with men. Clin Infect Dis. 2002;35(11):1382-7. doi: 10.1086/343044. [PubMed: 12439802].
  • 35. Soltani B, Sharif M, GhA M, Khademian M. Evaluation of serum hepatitis B antibody level in vaccinated children after 14 years in Kashan, Iran. J Gorgan Univ Med Sci. 2012;14(3):104-8.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments